Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C32H35NO13 |
Molecular Weight | 641.6192 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12O[C@]3([H])[C@H](C)O[C@H](C[C@]3([H])N1CCO[C@@H]2OC)O[C@H]4C[C@@](O)(CC5=C4C(O)=C6C(=O)C7=C(OC)C=CC=C7C(=O)C6=C5O)C(=O)CO
InChI
InChIKey=SLURUCSFDHKXFR-WWMWMSKMSA-N
InChI=1S/C32H35NO13/c1-13-29-16(33-7-8-43-31(42-3)30(33)46-29)9-20(44-13)45-18-11-32(40,19(35)12-34)10-15-22(18)28(39)24-23(26(15)37)25(36)14-5-4-6-17(41-2)21(14)27(24)38/h4-6,13,16,18,20,29-31,34,37,39-40H,7-12H2,1-3H3/t13-,16-,18-,20-,29+,30+,31-,32-/m0/s1
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
The interaction of nemorubicin metabolite PNU-159682 with DNA fragments d(CGTACG)(2), d(CGATCG)(2) and d(CGCGCG)(2) shows a strong but reversible binding to G:C base pairs. | 2012 Dec 15 |
|
Virtual Cross-Linking of the Active Nemorubicin Metabolite PNU-159682 to Double-Stranded DNA. | 2017 Feb 20 |
|
Highly Potent, Anthracycline-based Antibody-Drug Conjugates Generated by Enzymatic, Site-specific Conjugation. | 2017 May |
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CQ5A9ZNT7C
Created by
admin on Sat Dec 16 18:49:00 GMT 2023 , Edited by admin on Sat Dec 16 18:49:00 GMT 2023
|
PRIMARY | |||
|
9874188
Created by
admin on Sat Dec 16 18:49:00 GMT 2023 , Edited by admin on Sat Dec 16 18:49:00 GMT 2023
|
PRIMARY | |||
|
300000039898
Created by
admin on Sat Dec 16 18:49:00 GMT 2023 , Edited by admin on Sat Dec 16 18:49:00 GMT 2023
|
PRIMARY | |||
|
202350-68-3
Created by
admin on Sat Dec 16 18:49:00 GMT 2023 , Edited by admin on Sat Dec 16 18:49:00 GMT 2023
|
PRIMARY |
ACTIVE MOIETY